Jennifer Wilkie

COVID-19 Emergency Response Act: Amendments To The Patent Act

The USMCA: What Does It Mean For Patents And The Pharmaceutical Industry?

The Skinny On Skinny Labels

What The Supreme Court Of Canada Was Not Told About Patent Utility

Changes At PMPRB To Safeguard Against Excessively Priced Medicines

Health Canada Seeks Comment On Revised SEB Guidance Document: New Requirements For SEB Sponsors

PM(NOC) Regulation Amendments Now In Force

Industry Canada Seeks Comment On Proposed Changes To Listing Requirements Under The PM(NOC) Regulations

Federal Court Rejects NIA Defence And Awards Compound Interest On Patent Damages

Federal Court Determines Minister’s Decisions Granting NOCs Based On Administrative ANDSs Cross-Referencing Licensed Generics Without Requiring NOAs Are Wrong